Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739843 · ClinicalTrials.gov registry record
Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients
A clinical trial, sponsored by University of Chicago.
- Terminated
- Registry status
- 55
- Enrollment target
NCT00739843: Clinical Trial study, sponsored by University of Chicago.
NCT00739843 is a clinical trial that was terminated before completion, run by University of Chicago. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00739843 was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to estimate how quickly cognitive status and functional status in older patients on hemodialysis declines.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-09 |
Why NCT00739843 stopped before completion
NCT00739843 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00739843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00739843 about?
NCT00739843 is a clinical study titled "Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients". The purpose of this study is to estimate how quickly cognitive status and functional status in older patients on hemodialysis declines.
What is the current status of trial NCT00739843?
This trial is currently terminated. The enrollment target is 55 participants. The study started on 2007-11. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00739843?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia